Waters has announced that the Thomson Mass Spectrometry Laboratory at the Institute of Chemistry, University of Campinas (UNICAMP), Campinas, Brazil, has been recognized as a Centre of Innovation.
Waters has announced that the Thomson Mass Spectrometry Laboratory at the Institute of Chemistry, University of Campinas (UNICAMP), Campinas, Brazil, has been recognized as a Centre of Innovation. Waters has also recognized director of the laboratory, Dr Marcos Eberlin, for his work pioneering mass spectrometry.
Dr Eberlin has built up an impressive reputation as director of the world’s largest mass spectrometry research team. He has published almost 500 papers, is a member of a number of editorial boards and is co-founder and vice president of the Brazilian Mass Spectrometry Society (BrMASS).
Tim Riley, Waters’ Centres of Innovation Programme Director, commented, “The Thomson Laboratory is the most prestigious mass spectrometry laboratory in all of Latin America. Professor Eberlin’s contributions in the field of mass spectrometry are impressive and his enthusiasm for the subject and his passion for passing along his knowledge to his students are truly amazing. It is indeed an honour to be associated with him and his laboratory.”
Dr Eberlin said, “It’s been an honour for a laboratory in Brazil to be chosen as a Waters’ Centre of Innovation. The pioneering professors and students of the Institute of Chemistry deserve the credit for laying the groundwork that made it possible to be where we are today. There’s nothing better than to have our hard, pioneering work recognized. We’re really proud that our efforts are worthy of this honour and to be selected for the Waters’ Centres of Innovation Programme.”
The Thomson Laboratory is the first mass spectrometry laboratory in Latin America to be welcomed into the programme.
For more information please visit ref="http://www.waters.com">www.waters.com
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.